Related Blogs
(HGSI) Human Genome Sciences' ABthrax Faces FDA Delay | Stock Blog Hub
Recently,
Human Genome Sciences Inc. (
HGSI) announced that the US Food and Drug Administration (FDA) delayed the approval of ABthrax (raxibacumab), the.
Top Day Trader Alerts (CIT, DNDN, F, HGSI, MOT) – 24/7 Wall St.
Human Genome Sciences, Inc. (NASDAQ:
HGSI) is trading up over 30% at multi-year highs on its positive lupus study data at the higher dose. Motorola Inc. (NYSE: MOT) is running rather well today. The troubled phone and communications ...
Human Genome Sciences (HGSI) NewsBite - HGSI Hits 52-Week High on ...
Human Genome Sciences (NGM:
HGSI) hit a new 52-Week high of $26.21 so far today. Currently the stock is up $5.21 (27.88%) to $23.90 on 34868684 shares traded. Today's high is up $23.45 from a 52-Week Low of $0.45.
HGSI reported positive ...
Opening Drive (HGSI) | SMB Capital - Day Trading Blog
Opening Drive? Mike is that some football term describing a team's first possession? No. The Opening Drive is a play that momentum traders crush, leaving.
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
On 11/16/09 Cytori Therapeutics NASDAQ CYTX completed enrollment in a 70-patient international breast cancer reconstruction study RESTORE 2 The study.
Bank of America, Ford, HGSI, GSK, EAC, DNR, DF, BBT Popular Stocks ...
US stocks traded mixed Monday as the Dow Jones Industrial Average rose 15 points to 9727, the S&P 500 fell 1 point to 1035 and the Nasdaq Composite droped.